ABG-WTT Global Life Science Capital Partners GP Ltd
10% Owner

ABG-WTT Global Life Science Capital Partners GP Ltd insider trades: MedAvail Holdings (MDVL) stock purchases

10% Owner, MedAvail Holdings Last trade Apr 4, 2022 9 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2020
1
Company
last trade 2022

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where ABG-WTT Global Life Science Capital Partners GP Ltd reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Apr 4, 2022MDVL↑ Buy$15.0M
Dec 31, 2020MDVL↑ Buy$190K
Dec 29, 2020MDVL↑ Buy$101K
Dec 24, 2020MDVL↑ Buy$660K
Dec 21, 2020MDVL↑ Buy$470K
Dec 17, 2020MDVL↑ Buy$570K
Dec 15, 2020MDVL↑ Buy$556K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About ABG-WTT Global Life Science Capital Partners GP Ltd's insider trades

ABG-WTT Global Life Science Capital Partners GP Ltd is a 10% owner of MedAvail Holdings (MDVL). Since Dec 15, 2020, it has reported 7 open-market purchases worth $17.5M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Its filings also include other transactions (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDVL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.